ArticleFrontiers in oncology2025

Sugemalimab plus chemotherapy vs. chemotherapy for treatment of Chinese patients with esophageal squamous cell carcinoma: a cost effectiveness analysis to inform decision making.

Qiuping Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.